skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,337  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Database: HighWire Press (Free Journals) remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pleiotropic Effects of Statins on the Cardiovascular System
Material Type:
Article
Add to My Research

Pleiotropic Effects of Statins on the Cardiovascular System

Circulation research, 2017-01, Vol.120 (1), p.229-243 [Peer Reviewed Journal]

2017 American Heart Association, Inc. ;Copyright Lippincott Williams & Wilkins Ovid Technologies Jan 6, 2017 ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.116.308537 ;PMID: 28057795

Full text available

2
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries
Material Type:
Article
Add to My Research

Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries

Clinical chemistry (Baltimore, Md.), 2015-01, Vol.61 (1), p.231-238 [Peer Reviewed Journal]

2014 American Association for Clinical Chemistry. ;COPYRIGHT 2015 American Association for Clinical Chemistry, Inc. ;Copyright American Association for Clinical Chemistry Jan 2015 ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2014.231365 ;PMID: 25414277

Full text available

3
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Material Type:
Article
Add to My Research

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

Circulation (New York, N.Y.), 2018-01, Vol.137 (4), p.338-350 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.032235 ;PMID: 29133605

Full text available

4
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology
Material Type:
Article
Add to My Research

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology

Circulation research, 2016-02, Vol.118 (4), p.547-563 [Peer Reviewed Journal]

2016 American Heart Association, Inc. ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.115.306249 ;PMID: 26892957

Full text available

5
Quantifying Importance of Major Risk Factors for Coronary Heart Disease
Material Type:
Article
Add to My Research

Quantifying Importance of Major Risk Factors for Coronary Heart Disease

Circulation (New York, N.Y.), 2019-03, Vol.139 (13), p.1603-1611 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 The Authors. 2018 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.031855 ;PMID: 30586759

Full text available

6
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
Material Type:
Article
Add to My Research

Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation

Clinical chemistry (Baltimore, Md.), 2021-01, Vol.67 (1), p.143-153 [Peer Reviewed Journal]

American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2020 ;American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;COPYRIGHT 2021 American Association for Clinical Chemistry, Inc. ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1093/clinchem/hvaa252 ;PMID: 33257928

Full text available

7
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial
Material Type:
Article
Add to My Research

High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial

Circulation (New York, N.Y.), 2018-05, Vol.137 (19), p.1997-2009 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 The Authors. ;2018 The Authors. 2018 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.032615 ;PMID: 29735587

Full text available

8
Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases
Material Type:
Article
Add to My Research

Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases

Science (American Association for the Advancement of Science), 2016-08, Vol.353 (6301), p.827 [Peer Reviewed Journal]

ISSN: 1095-9203 ;EISSN: 1095-9203 ;DOI: 10.1126/science.aad6970

Digital Resources/Online E-Resources

9
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up
Material Type:
Article
Add to My Research

Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up

Circulation (New York, N.Y.), 2017-11, Vol.136 (20), p.1878-1891 [Peer Reviewed Journal]

2017 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.027966 ;PMID: 28877913

Full text available

10
Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically
Material Type:
Article
Add to My Research

Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically

Arteriosclerosis, thrombosis, and vascular biology, 2016-12, Vol.36 (12), p.2439-2445 [Peer Reviewed Journal]

2016 American Heart Association, Inc. ;ISSN: 1079-5642 ;EISSN: 1524-4636 ;DOI: 10.1161/ATVBAHA.116.308027 ;PMID: 27765764

Full text available

11
Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study
Material Type:
Article
Add to My Research

Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study

Stroke (1970), 2018-04, Vol.49 (4), p.820-827 [Peer Reviewed Journal]

2018 American Heart Association, Inc. ;2018 The Authors. ;2018 The Authors. 2018 ;ISSN: 0039-2499 ;ISSN: 1524-4628 ;EISSN: 1524-4628 ;DOI: 10.1161/STROKEAHA.117.019653 ;PMID: 29535274

Full text available

12
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models
Material Type:
Article
Add to My Research

Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models

Circulation (New York, N.Y.), 2023-01, Vol.147 (3), p.242-253 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.062132 ;PMID: 36314243

Full text available

13
A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL[S]
Material Type:
Article
Add to My Research

A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL[S]

Journal of lipid research, 2013-07, Vol.54 (7), p.1812-1824 [Peer Reviewed Journal]

2013 © 2013 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. ;Copyright © 2013 by the American Society for Biochemistry and Molecular Biology, Inc. 2013 ;ISSN: 0022-2275 ;EISSN: 1539-7262 ;DOI: 10.1194/jlr.M034330 ;PMID: 23670529

Full text available

14
Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs
Material Type:
Article
Add to My Research

Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs

Arteriosclerosis, thrombosis, and vascular biology, 2013-06, Vol.33 (6), p.1392-1400 [Peer Reviewed Journal]

ISSN: 1079-5642 ;EISSN: 1524-4636 ;DOI: 10.1161/atvbaha.112.300741 ;PMID: 23559634

Full text available

15
Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population
Material Type:
Article
Add to My Research

Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population

Clinical chemistry (Baltimore, Md.), 2015-03, Vol.61 (3), p.533-543 [Peer Reviewed Journal]

2015 American Association for Clinical Chemistry. ;COPYRIGHT 2015 American Association for Clinical Chemistry, Inc. ;Copyright American Association for Clinical Chemistry Mar 2015 ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2014.234146 ;PMID: 25605681

Full text available

16
Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
Material Type:
Article
Add to My Research

Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia

Circulation (New York, N.Y.), 2013-11, Vol.128 (19), p.2113-2120 [Peer Reviewed Journal]

2013 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2014 INIST-CNRS ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.113.004678 ;PMID: 24014831 ;CODEN: CIRCAZ

Full text available

17
Measuring LDL cholesterol: for old and new calculations, is there an optimal formula?
Material Type:
Article
Add to My Research

Measuring LDL cholesterol: for old and new calculations, is there an optimal formula?

Clinical chemistry (Baltimore, Md.), 2015-12, Vol.61 (12), p.1466 [Peer Reviewed Journal]

COPYRIGHT 2015 American Association for Clinical Chemistry, Inc. ;ISSN: 0009-9147 ;EISSN: 1530-8561

Full text available

18
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis
Material Type:
Article
Add to My Research

Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis

Circulation research, 2016-02, Vol.118 (4), p.579-585 [Peer Reviewed Journal]

2016 American Heart Association, Inc. ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.115.306398 ;PMID: 26892959

Full text available

19
Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control
Material Type:
Article
Add to My Research

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control

Circulation (New York, N.Y.), 2016-12, Vol.134 (24), p.1931-1943 [Peer Reviewed Journal]

2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 The Authors. ;2016 The Authors. 2016 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.024604 ;PMID: 27777279

Full text available

20
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Material Type:
Article
Add to My Research

The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism

Circulation (New York, N.Y.), 2020-05, Vol.141 (20), p.1600-1607 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.046397 ;PMID: 32223429

Full text available

Results 1 - 20 of 3,337  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (3,224)

Refine My Results

Creation Date 

From To
  1. Before 1989  (147)
  2. 1989 To 1996  (481)
  3. 1997 To 2004  (864)
  4. 2005 To 2013  (893)
  5. After 2013  (952)
  6. More options open sub menu

Language 

  1. English  (3,336)
  2. Japanese  (761)
  3. Russian  (3)
  4. French  (3)
  5. Norwegian  (3)
  6. More options open sub menu

Searching Remote Databases, Please Wait